MyModernHealth FAQs Series Read Description

Psychedelic Drug Treatments

Assisting the Therapeutic Process

Paperback
March 2016
9781936420445
More details
  • Publisher
    Mercury Learning & Information
  • Published
    8th March 2016
  • ISBN 9781936420445
  • Language English
  • Pages 60 pp.
  • Size 6" x 9"
$24.95
E-Book
February 2016
9781937585594
More details
  • Publisher
    Mercury Learning & Information
  • Published
    29th February 2016
  • ISBN 9781937585594
  • Language English
  • Pages 60 pp.
  • Size 6" x 9"
$19.95
Lib E-Book

Library E-Books

We have signed up with three aggregators who resell networkable e-book editions of our titles to academic libraries. These aggregators offer a variety of plans to libraries, such as simultaneous access by multiple library patrons, and access to portions of titles at a fraction of list price under what is commonly referred to as a “patron-driven demand” model.

These editions, priced at par with simultaneous hardcover editions of our titles, are not available direct from Stylus, but only from the following aggregators:

  • Ebook Library, a service of Ebooks Corporation Ltd. of Australia
  • ebrary, based in Palo Alto, a subsidiary of ProQuest
  • EBSCO / netLibrary, Alabama

as well as through the following wholesalers: The Yankee Book Peddler subsidiary of Baker & Taylor, Inc.

February 2016
9781937585587
More details
  • Publisher
    Mercury Learning & Information
  • Published
    29th February 2016
  • ISBN 9781937585587
  • Language English
  • Pages 60 pp.
  • Size 6" x 9"
$74.95

Psychedelic Drug Treatments: Assisting the Therapeutic Process provides information about current and quite viable investigation into reviving and progressing with neurological research that began in the middle of the 20th century and was brought to a halt when certain drugs were banned in the 1970s. Using a question/answer format, the book will introduce you to the way in which the chemical compounds known as psychedelics affect the brain, provide you with the definitions of key terms particular to the neurological and psychological vocabulary, describe the specific disorders that can realistically be helped or relieved through treatment with psychedelics, and offer information with regard to current research being conducted in the field. This text will discuss the history of the earlier research efforts and will examine the likelihood of a resurgence of interest in the successful development of methods and practices of clinical therapy assisted by psychedelic drugs. The purpose of this volume is to promote an understanding of the use of psychedelics as tools to assist therapy and to challenge the 40-year-old prejudices against research into the possible benefits of these drugs.

Features:

•Questions and answers about the history, research, and treatments related to psychedelic drugs

•Makes a case for the re-evaluation of psychedelics — LSD, MDMA (‘ecstasy’), DMT, psilocybin, ayahuasca, peyote, ibogaine, and more — and their clinical potential for treating a range of conditions from post-traumatic stress disorder and depression to autism and cluster headaches.

•Includes numerous in-text resources such as links to Web sites, videos, articles, blogs, etc. from NIH, FDA, YouTube, and university/clinical studies

Ben Sessa

Ben Sessa is a NHS Consultant Child and Adolescent Psychiatrist working in Taunton, Somerset (UK) with children and young people with a wide range of severe mental disorders. He trained in medicine at University College London and is a member of the Royal College of Psychiatrists.

Eileen Worthley

Eileen Worthley (Boston, MA) is a publishing professional who has worked as an editor of texts and journals in the health sciences.